Skip to main content
. Author manuscript; available in PMC: 2024 May 16.
Published in final edited form as: Lancet Glob Health. 2024 May;12(5):e859–e867. doi: 10.1016/S2214-109X(24)00051-2

Table 1:

Characteristics of index participants

Index participants (n=989)

Age, years 37 (31–42)
Sex
 Female 485 (49%)
 Male 504 (51%)
Marital status
 Married 220 (22%)
 Unmarried 769 (78%)
Region
 Nairobi 532 (54%)
 Coast 457 (46%)
Violence in past year
 Physical 338 (34%)
 Sexual 87 (9%)
 Threatened 185 (19%)
Injection history and risk behaviours
 Needle sharing in past month 68 (7%)
 Equipment sharing in past month 106 (11%)
 Time injecting drugs, years 5 (2–7)
 Monthly frequency of injecting 60 (30–90)
 Sexual encounters in past month 2(0–10)
 Lifetime sexual partners 15 (6–50)
 Condom use during last sexual intercourse* 553 (56%)
 Transactional sex, ever 760 (77%)
 On methadone 228 (23%)
HIV and HCV data
 HCV antibody positive 162 (16%)
 HCV viraemia 73 (7%)
 Previously treated with direct-acting antivirals 27 (3%)
 Engaged in HIV care 855 (86%)
 On antiretroviral therapy 800(81%)
 Viral suppression of HIV 535 (68%)
Partners
 Also enrolled as partner§ 502 (51%)
 Number of partners mentioned
  1–5 723 (73%)
  6–10 233 (24%)
  >10 33 (3%)

Data are n (%) or median (IQR). Index participants were people who inject drugs and were living with HIV. HCV=hepatitis C virus.

*

Defined as vaginal, oral, or anal penetrative sex.

Defined as giving or receiving money or material goods in exchange for sex.

Data were unavailable for 201 participants, so the denominator for this percentage calculation was 788.

§

Also named as partners and thus represented again in table 2.